ArticleHealth promotion international2026
The influence of the pharmaceutical industry and the pharmacy sector on Aboriginal and Torres Strait Islander health: a yarning study.
Article in Health promotion international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
While pharmaceutical companies develop life-saving medicines and the pharmacy sector is integral to healthcare delivery, entities within the medicines sector can also operate as powerful commercial actors. The practices of the pharmaceutical industry and the pharmacy sector warrant scrutiny through a commercial determinants of health lens. This is particularly important for Indigenous peoples, who experience inequities within Western healthcare systems while also holding enduring cultural knowledge of traditional medicines. Despite increasing international attention to the practices of the pharmaceutical industry, the influence of the medicines sector, as a whole, on Aboriginal and Torres Strait Islander peoples in Australia has not previously been examined. This study aimed to examine the systems, practices and pathways through which the pharmaceutical industry and the pharmacy sector may influence Aboriginal and Torres Strait Islander health and wellbeing. We applied the Aboriginal research method of Yarning to explore the perspectives and experiences of ten Aboriginal/Torres Strait Islander and nine non-Indigenous participants with expertise relevant to the pharmaceutical industry and/or the pharmacy sector. Five themes revealed tensions between commercial models within the pharmacy sector and community needs; regulatory marginalization of cultural medicines and the need to protect Indigenous cultural and intellectual property; pharmaceutical industry efforts to partner with Aboriginal organizations; the lobbying power of peak pharmacy sector bodies; and opportunities for genuine collaboration. Strengthening culturally safe practice, embedding pharmacists within Aboriginal Community Controlled Health Services, and elevating Aboriginal and Torres Strait Islander governance across the medicines sector are critical to addressing power imbalances and advancing health equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.